358 related articles for article (PubMed ID: 32289231)
21. Characteristics of undertreatment in COPD in the general population.
Ingebrigtsen TS; Marott JL; Vestbo J; Hallas J; Nordestgaard BG; Dahl M; Lange P
Chest; 2013 Dec; 144(6):1811-1818. PubMed ID: 23989916
[TBL] [Abstract][Full Text] [Related]
22. The effect of changes to GOLD severity stage on long term morbidity and mortality in COPD.
Flynn RWV; MacDonald TM; Chalmers JD; Schembri S
Respir Res; 2018 Dec; 19(1):249. PubMed ID: 30541559
[TBL] [Abstract][Full Text] [Related]
23. Impact of exacerbations on respiratory system impedance measured by a forced oscillation technique in COPD: a prospective observational study.
Kamada T; Kaneko M; Tomioka H
Int J Chron Obstruct Pulmon Dis; 2017; 12():509-516. PubMed ID: 28223791
[TBL] [Abstract][Full Text] [Related]
24. Growth differentiation factor-15 is a predictor of important disease outcomes in patients with COPD.
Husebø GR; Grønseth R; Lerner L; Gyuris J; Hardie JA; Bakke PS; Eagan TM
Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28298399
[TBL] [Abstract][Full Text] [Related]
25. Does Low FEV1 in Addition to Fixed Ratio and/or Lower Limit of Normal of FEV1/FVC Improve Prediction of Mortality in COPD? The NHANES-III-linked-mortality Cohort.
Odeyemi YE; Lewis O; Ngwa J; Dodd K; Gillum RF; Mehari A
J Natl Med Assoc; 2019 Feb; 111(1):94-100. PubMed ID: 30064691
[TBL] [Abstract][Full Text] [Related]
26. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease.
Soler-Cataluña JJ; Martínez-García MA; Román Sánchez P; Salcedo E; Navarro M; Ochando R
Thorax; 2005 Nov; 60(11):925-31. PubMed ID: 16055622
[TBL] [Abstract][Full Text] [Related]
27. Lung Function and the Risk of Exacerbation in the β-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease Trial.
Parekh TM; Helgeson ES; Connett J; Voelker H; Ling SX; Lazarus SC; Bhatt SP; MacDonald DM; Mkorombindo T; Kunisaki KM; Fortis S; Kaminsky D; Dransfield MT
Ann Am Thorac Soc; 2022 Oct; 19(10):1642-1649. PubMed ID: 35363600
[No Abstract] [Full Text] [Related]
28. Impact of restrictive versus obstructive pulmonary function patterns on mortality in patients undergoing transcatheter aortic valve implantation.
Escárcega RO; Torguson R; Tavil-Shatelyan A; Daoud Y; Koifman E; Kiramijyan S; Gai J; Satler LF; Pichard AD; Waksman R
Cardiovasc Revasc Med; 2016; 17(3):181-5. PubMed ID: 26997471
[TBL] [Abstract][Full Text] [Related]
29. Determination of the efficacy of FEV6 as a surrogate for FVC in the diagnostic screening for chronic obstructive pulmonary disease through the comparison of FEV1/FVC and FEV1/FEV6 ratios.
Lundgren FL; Cabral MM; Clímaco DC; de Macedo LG; Coelho Mde A; Dias AL
J Bras Pneumol; 2007; 33(2):148-51. PubMed ID: 17724533
[TBL] [Abstract][Full Text] [Related]
30. Childhood Lung Function Predicts Adult Chronic Obstructive Pulmonary Disease and Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome.
Bui DS; Burgess JA; Lowe AJ; Perret JL; Lodge CJ; Bui M; Morrison S; Thompson BR; Thomas PS; Giles GG; Garcia-Aymerich J; Jarvis D; Abramson MJ; Walters EH; Matheson MC; Dharmage SC
Am J Respir Crit Care Med; 2017 Jul; 196(1):39-46. PubMed ID: 28146643
[TBL] [Abstract][Full Text] [Related]
31. Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study.
Mannino DM; Buist AS; Petty TL; Enright PL; Redd SC
Thorax; 2003 May; 58(5):388-93. PubMed ID: 12728157
[TBL] [Abstract][Full Text] [Related]
32. Decline in FEV
Hiller AM; Piitulainen E; Jehpsson L; Tanash H
Int J Chron Obstruct Pulmon Dis; 2019; 14():1075-1083. PubMed ID: 31213789
[No Abstract] [Full Text] [Related]
33. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C
Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820
[TBL] [Abstract][Full Text] [Related]
34. Quantitative assessment of pulmonary vascular alterations in chronic obstructive lung disease: Associations with pulmonary function test and survival in the KOLD cohort.
Cho YH; Lee SM; Seo JB; Kim N; Bae JP; Lee JS; Oh YM; Do-Lee S
Eur J Radiol; 2018 Nov; 108():276-282. PubMed ID: 30396668
[TBL] [Abstract][Full Text] [Related]
35. Lung function, respiratory symptoms and venous thromboembolism risk: the Atherosclerosis Risk in Communities Study.
Kubota Y; London SJ; Cushman M; Chamberlain AM; Rosamond WD; Heckbert SR; Zakai N; Folsom AR
J Thromb Haemost; 2016 Dec; 14(12):2394-2401. PubMed ID: 27696765
[TBL] [Abstract][Full Text] [Related]
36. Trajectory of Preserved Ratio Impaired Spirometry: Natural History and Long-Term Prognosis.
Marott JL; Ingebrigtsen TS; Çolak Y; Vestbo J; Lange P
Am J Respir Crit Care Med; 2021 Oct; 204(8):910-920. PubMed ID: 34233141
[No Abstract] [Full Text] [Related]
37. Prognostic utility of admission cell-free DNA levels in patients with chronic obstructive pulmonary disease exacerbations.
Avriel A; Rozenberg D; Raviv Y; Heimer D; Bar-Shai A; Gavish R; Sheynin J; Douvdevani A
Int J Chron Obstruct Pulmon Dis; 2016; 11():3153-3161. PubMed ID: 28003743
[TBL] [Abstract][Full Text] [Related]
38. Combined effect of lung function level and decline increases morbidity and mortality risks.
Baughman P; Marott JL; Lange P; Martin CJ; Shankar A; Petsonk EL; Hnizdo E
Eur J Epidemiol; 2012 Dec; 27(12):933-43. PubMed ID: 23238697
[TBL] [Abstract][Full Text] [Related]
39. Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.
Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D
Health Technol Assess; 2019 Jul; 23(37):1-146. PubMed ID: 31343402
[TBL] [Abstract][Full Text] [Related]
40. Comparison of five major airflow limitation criteria to identify high-risk individuals with COPD: a contemporary population-based cohort.
Çolak Y; Nordestgaard BG; Vestbo J; Lange P; Afzal S
Thorax; 2020 Nov; 75(11):944-954. PubMed ID: 32820083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
